Report Detail

Request for Sample of this report

Pharma & Healthcare Global Clavulanate Potassium Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4739635
    • |
  • 08 September, 2026
    • |
  • Global
    • |
  • 96 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Clavulanate Potassium market size was valued at US$ 481 million in 2025 and is forecast to a readjusted size of US$ 691 million by 2032 with a CAGR of 5.1% during review period.
Potassium Clavulanate is the pharmaceutical-grade potassium salt of clavulanic acid, produced through microbial fermentation, downstream separation, purification, salt formation and drying. It acts as a beta-lactamase inhibitor and is normally combined with beta-lactam antibiotics, particularly amoxicillin.
The scope includes pure potassium clavulanate, sterile and non-sterile grades, and stabilized products diluted with microcrystalline cellulose or colloidal silicon dioxide. Sales volume is normalized to potassium clavulanate active equivalent, or KGA.
Finished amoxicillin-clavulanate medicines, premixed amoxicillin sodium and potassium clavulanate compound APIs, fermentation intermediates, reference standards and trading-only activities are excluded.
The 2025 ASP is US$190/kg, global sales volume is approximately 2.462k tons, and the estimated average gross margin is approximately 30%.
The upstream chain includes fermentation strains, carbohydrate and nitrogen fermentation media, solvents, purification materials, potassium salt-forming agents, microcrystalline cellulose, colloidal silicon dioxide and pharmaceutical packaging materials. Midstream activities include fermentation, broth clarification, extraction, purification, crystallization, aseptic processing, drying, stabilization, quality testing and regulatory-document preparation. Downstream users mainly include compound-API producers and manufacturers of oral, injectable and veterinary amoxicillin-clavulanate formulations.
Demand for potassium clavulanate is fundamentally linked to the use of amoxicillin-clavulanate and other beta-lactam/beta-lactamase inhibitor combinations. Potassium clavulanate is not normally marketed as a standalone therapeutic product.
Oral formulations represent the largest consumption channel, including tablets, dispersible tablets, dry syrups and pediatric suspensions. Sterile injectable applications have lower volumes but higher requirements for microbial control, aseptic processing, impurity limits and regulatory documentation.
Commercial supply is divided between pure potassium clavulanate and stabilized diluted forms. Because the molecule is sensitive to moisture and processing conditions, microcrystalline cellulose and colloidal silicon dioxide are commonly used to improve handling and support downstream formulation.
Price comparisons must be made on a KGA basis. Comparing the price per kilogram of a 1:1 diluted product with the price per kilogram of pure potassium clavulanate would produce a misleading procurement conclusion.
Production has relatively high technical barriers. Fermentation productivity, recovery yield, temperature and moisture control, purification efficiency and stability during drying all affect manufacturing economics and final product quality.
The market remains concentrated among manufacturers with established fermentation capacity and regulatory registrations. CEP, USDMF and other country-specific filings are important because changing an API supplier may require formulation manufacturers to complete additional validation and regulatory procedures.
China remains one of the major global production and export bases. India is expanding local production under pharmaceutical raw-material localization policies, while also maintaining a minimum import price for low-priced potassium clavulanate imports through November 30, 2026.
Future competition will focus on fermentation cost, active-content yield, impurity control, regulatory-file coverage, sterile manufacturing capability and supply reliability rather than on major changes to the molecule itself.
Antimicrobial-resistance policies may limit unnecessary antibiotic use, but they also increase the importance of standardized, quality-controlled combination products. Demand growth should therefore be viewed as moderate rather than unrestricted.
Report Scope
This report is a detailed and comprehensive analysis for global Clavulanate Potassium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Clavulanate Potassium market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/kg), 2021-2032
Global Clavulanate Potassium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/kg), 2021-2032
Global Clavulanate Potassium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/kg), 2021-2032
Global Clavulanate Potassium market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Clavulanate Potassium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Clavulanate Potassium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sinopharm Weiqida Pharmaceutical Co., Ltd., Zhuhai United Laboratories Co., Ltd., Shandong New Time Pharmaceutical Co., Ltd., Shanxi Shuangyan Pharmaceutical Co., Ltd., CKD Bio Corporation, Lek Pharmaceuticals d.d., Fermic, S.A. de C.V., Kinvan Private Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Clavulanate Potassium market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Below 5 kg
5–20 kg
Above 20 kg
Market segment by Sourcing Strategy
Single-source Procurement
Dual-source Procurement
Multi-source Procurement
Captive Internal Supply
Market segment by Sterility
Non-sterile Grade
Sterile Grade
Market segment by Application
Human Oral Anti-infectives
Human Injectable Anti-infectives
Veterinary Anti-infectives
Other Pharmaceutical Applications
Major players covered
Sinopharm Weiqida Pharmaceutical Co., Ltd.
Zhuhai United Laboratories Co., Ltd.
Shandong New Time Pharmaceutical Co., Ltd.
Shanxi Shuangyan Pharmaceutical Co., Ltd.
CKD Bio Corporation
Lek Pharmaceuticals d.d.
Fermic, S.A. de C.V.
Kinvan Private Limited
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Clavulanate Potassium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Clavulanate Potassium, with price, sales quantity, revenue, and global market share of Clavulanate Potassium from 2021 to 2026.
Chapter 3, the Clavulanate Potassium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Clavulanate Potassium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Clavulanate Potassium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Clavulanate Potassium.
Chapter 14 and 15, to describe Clavulanate Potassium sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Clavulanate Potassium Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Below 5 kg
    • 1.3.3 5–20 kg
    • 1.3.4 Above 20 kg
  • 1.4 Market Analysis by Sourcing Strategy
    • 1.4.1 Overview: Global Clavulanate Potassium Consumption Value by Sourcing Strategy: 2021 Versus 2025 Versus 2032
    • 1.4.2 Single-source Procurement
    • 1.4.3 Dual-source Procurement
    • 1.4.4 Multi-source Procurement
    • 1.4.5 Captive Internal Supply
  • 1.5 Market Analysis by Sterility
    • 1.5.1 Overview: Global Clavulanate Potassium Consumption Value by Sterility: 2021 Versus 2025 Versus 2032
    • 1.5.2 Non-sterile Grade
    • 1.5.3 Sterile Grade
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Clavulanate Potassium Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Human Oral Anti-infectives
    • 1.6.3 Human Injectable Anti-infectives
    • 1.6.4 Veterinary Anti-infectives
    • 1.6.5 Other Pharmaceutical Applications
  • 1.7 Global Clavulanate Potassium Market Size & Forecast
    • 1.7.1 Global Clavulanate Potassium Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Clavulanate Potassium Sales Quantity (2021-2032)
    • 1.7.3 Global Clavulanate Potassium Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sinopharm Weiqida Pharmaceutical Co., Ltd.
    • 2.1.1 Sinopharm Weiqida Pharmaceutical Co., Ltd. Details
    • 2.1.2 Sinopharm Weiqida Pharmaceutical Co., Ltd. Major Business
    • 2.1.3 Sinopharm Weiqida Pharmaceutical Co., Ltd. Clavulanate Potassium Product and Services
    • 2.1.4 Sinopharm Weiqida Pharmaceutical Co., Ltd. Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sinopharm Weiqida Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.2 Zhuhai United Laboratories Co., Ltd.
    • 2.2.1 Zhuhai United Laboratories Co., Ltd. Details
    • 2.2.2 Zhuhai United Laboratories Co., Ltd. Major Business
    • 2.2.3 Zhuhai United Laboratories Co., Ltd. Clavulanate Potassium Product and Services
    • 2.2.4 Zhuhai United Laboratories Co., Ltd. Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Zhuhai United Laboratories Co., Ltd. Recent Developments/Updates
  • 2.3 Shandong New Time Pharmaceutical Co., Ltd.
    • 2.3.1 Shandong New Time Pharmaceutical Co., Ltd. Details
    • 2.3.2 Shandong New Time Pharmaceutical Co., Ltd. Major Business
    • 2.3.3 Shandong New Time Pharmaceutical Co., Ltd. Clavulanate Potassium Product and Services
    • 2.3.4 Shandong New Time Pharmaceutical Co., Ltd. Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shandong New Time Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.4 Shanxi Shuangyan Pharmaceutical Co., Ltd.
    • 2.4.1 Shanxi Shuangyan Pharmaceutical Co., Ltd. Details
    • 2.4.2 Shanxi Shuangyan Pharmaceutical Co., Ltd. Major Business
    • 2.4.3 Shanxi Shuangyan Pharmaceutical Co., Ltd. Clavulanate Potassium Product and Services
    • 2.4.4 Shanxi Shuangyan Pharmaceutical Co., Ltd. Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shanxi Shuangyan Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.5 CKD Bio Corporation
    • 2.5.1 CKD Bio Corporation Details
    • 2.5.2 CKD Bio Corporation Major Business
    • 2.5.3 CKD Bio Corporation Clavulanate Potassium Product and Services
    • 2.5.4 CKD Bio Corporation Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CKD Bio Corporation Recent Developments/Updates
  • 2.6 Lek Pharmaceuticals d.d.
    • 2.6.1 Lek Pharmaceuticals d.d. Details
    • 2.6.2 Lek Pharmaceuticals d.d. Major Business
    • 2.6.3 Lek Pharmaceuticals d.d. Clavulanate Potassium Product and Services
    • 2.6.4 Lek Pharmaceuticals d.d. Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Lek Pharmaceuticals d.d. Recent Developments/Updates
  • 2.7 Fermic, S.A. de C.V.
    • 2.7.1 Fermic, S.A. de C.V. Details
    • 2.7.2 Fermic, S.A. de C.V. Major Business
    • 2.7.3 Fermic, S.A. de C.V. Clavulanate Potassium Product and Services
    • 2.7.4 Fermic, S.A. de C.V. Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Fermic, S.A. de C.V. Recent Developments/Updates
  • 2.8 Kinvan Private Limited
    • 2.8.1 Kinvan Private Limited Details
    • 2.8.2 Kinvan Private Limited Major Business
    • 2.8.3 Kinvan Private Limited Clavulanate Potassium Product and Services
    • 2.8.4 Kinvan Private Limited Clavulanate Potassium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Kinvan Private Limited Recent Developments/Updates

3 Competitive Environment: Clavulanate Potassium by Manufacturer

  • 3.1 Global Clavulanate Potassium Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Clavulanate Potassium Revenue by Manufacturer (2021-2026)
  • 3.3 Global Clavulanate Potassium Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Clavulanate Potassium by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Clavulanate Potassium Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Clavulanate Potassium Manufacturer Market Share in 2025
  • 3.5 Clavulanate Potassium Market: Overall Company Footprint Analysis
    • 3.5.1 Clavulanate Potassium Market: Region Footprint
    • 3.5.2 Clavulanate Potassium Market: Company Product Type Footprint
    • 3.5.3 Clavulanate Potassium Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Clavulanate Potassium Market Size by Region
    • 4.1.1 Global Clavulanate Potassium Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Clavulanate Potassium Consumption Value by Region (2021-2032)
    • 4.1.3 Global Clavulanate Potassium Average Price by Region (2021-2032)
  • 4.2 North America Clavulanate Potassium Consumption Value (2021-2032)
  • 4.3 Europe Clavulanate Potassium Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Clavulanate Potassium Consumption Value (2021-2032)
  • 4.5 South America Clavulanate Potassium Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Clavulanate Potassium Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Clavulanate Potassium Sales Quantity by Type (2021-2032)
  • 5.2 Global Clavulanate Potassium Consumption Value by Type (2021-2032)
  • 5.3 Global Clavulanate Potassium Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Clavulanate Potassium Sales Quantity by Application (2021-2032)
  • 6.2 Global Clavulanate Potassium Consumption Value by Application (2021-2032)
  • 6.3 Global Clavulanate Potassium Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Clavulanate Potassium Sales Quantity by Type (2021-2032)
  • 7.2 North America Clavulanate Potassium Sales Quantity by Application (2021-2032)
  • 7.3 North America Clavulanate Potassium Market Size by Country
    • 7.3.1 North America Clavulanate Potassium Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Clavulanate Potassium Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Clavulanate Potassium Sales Quantity by Type (2021-2032)
  • 8.2 Europe Clavulanate Potassium Sales Quantity by Application (2021-2032)
  • 8.3 Europe Clavulanate Potassium Market Size by Country
    • 8.3.1 Europe Clavulanate Potassium Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Clavulanate Potassium Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Clavulanate Potassium Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Clavulanate Potassium Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Clavulanate Potassium Market Size by Region
    • 9.3.1 Asia-Pacific Clavulanate Potassium Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Clavulanate Potassium Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Clavulanate Potassium Sales Quantity by Type (2021-2032)
  • 10.2 South America Clavulanate Potassium Sales Quantity by Application (2021-2032)
  • 10.3 South America Clavulanate Potassium Market Size by Country
    • 10.3.1 South America Clavulanate Potassium Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Clavulanate Potassium Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Clavulanate Potassium Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Clavulanate Potassium Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Clavulanate Potassium Market Size by Country
    • 11.3.1 Middle East & Africa Clavulanate Potassium Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Clavulanate Potassium Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Clavulanate Potassium Market Drivers
  • 12.2 Clavulanate Potassium Market Restraints
  • 12.3 Clavulanate Potassium Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Clavulanate Potassium and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Clavulanate Potassium
  • 13.3 Clavulanate Potassium Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Clavulanate Potassium Typical Distributors
  • 14.3 Clavulanate Potassium Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Clavulanate Potassium. Industry analysis & Market Report on Clavulanate Potassium is a syndicated market report, published as Global Clavulanate Potassium Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Clavulanate Potassium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo